Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nao Otsuka has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Endoscopic Management of Choledocholithiasis in the Elderly: Balancing Safety and Effectiveness in the Aging Era

    by Ryunosuke Hakuta, Ryota Nakabayashi, Nao Otsuka, Noriko Ishigaki, Yukiko Takayama, Yousuke Nakai

    Endoscopic retrograde cholangiopancreatography (ERCP) is recommended as a first‐line treatment for bile duct stones in multiple guidelines. Although ERCP is an established and effective procedure, it is associated with early adverse events, particularly in elderly patients. Older individuals frequently have multiple comorbidities, are often treated with antithrombotic agents, and may have underlying oropharyngeal dysphagia, all of which increase the risk of complications such as bleeding, hypotension, and aspiration pneumonia. In addition, bile duct stones in elderly patients tend to be larger and more numerous, and the high prevalence of periampullary diverticula may limit the extent of endoscopic sphincterotomy, thereby prolonging procedure time and increasing procedural complexity. Recent evidence has also demonstrated an association between frailty and post‐ERCP mortality. While definitive stent placement without stone extraction could be a treatment option, it should only be considered in very elderly patients with significant frailty and limited life expectancy since endoscopic stone removal reduces long‐term biliary events and subsequent mortality. In patients with concomitant cholangitis, urgent biliary drainage reduces mortality regardless of severity. However, because elderly patients are at increased risk of periprocedural hypotension and aspiration pneumonia, urgent ERCP should be performed with careful monitoring and meticulous supportive management. In summary, treatment decisions should not be based solely on chronological age but should incorporate a comprehensive assessment of overall physical condition, including frailty.


  • Endoscopic Ultrasound‐Guided Hepaticocolonostomy Through the Reconstructed Colon

    by Nao Otsuka, Ryunosuke Hakuta, Yousuke Nakai

    Watch a video of this article.

  • Open Access

    Endoscopic approach to indeterminate biliary strictures

    by Yousuke Nakai, Ryunosuke Hakuta, Yutaka Shimamatsu, Nao Otsuka, Yukiko Takayama

    Diagnosis of biliary strictures remains challenging because of the low sensitivity of conventional transpapillary sampling using endoscopic retrograde cholangiopancreatography. New devices and tips have been developed to increase the diagnostic yield of conventional transpapillary sampling. However, additional endoscopic procedures are often necessary for indeterminate biliary strictures. Two major approaches for indeterminate biliary strictures are endoscopic ultrasonography-guided sampling and peroral cholangioscopy (POCS)-guided biopsy. The selection of modalities should be considered based on the stricture location. Although endoscopic ultrasound is the preferred approach for distal biliary strictures, POCS is preferred for perihilar biliary strictures. Endoscopic ultrasonography-guided sampling is highly sensitive in cases with a mass, but the sensitivity of POCS-guided biopsies is unsatisfactory, and discrepancy with the visual diagnosis of POCS is common. Whether these advanced techniques should be performed as the initial procedure or as a rescue after a failed diagnosis by conventional transpapillary sampling needs to be clarified in terms of diagnostic yield and cost-effectiveness.


  • Open Access

    Primary Endoscopic Ultrasound-Guided Biliary Drainage for Malignant Biliary Obstruction

    by Yousuke Nakai, Ryunosuke Hakuta, Ryota Nakabayashi, Yutaka Shimamatsu, Nao Otsuka, Yukiko Takayama

    Endoscopic ultrasound-guided biliary drainage (EUS-BD) has emerged as an important alternative to transpapillary biliary drainage by endoscopic retrograde cholangiopancreatography (ERCP) for malignant biliary obstruction (MBO), especially in cases with failed ERCP. Given the increasing evidences of safety and effectiveness of EUS-BD, EUS-BD as primary biliary drainage has been investigated in clinical trials. However, there are still obstacles that need to be addressed prior to clinical application. In this narrative review, clinical outcomes, hurdles and future perspectives of primary EUS-BD for MBO are discussed.

  • Open Access

    Fatty Pancreas: Its Potential as a Risk Factor for Pancreatic Cancer and Clinical Implications

    by Nao Otsuka, Yutaka Shimamatsu, Ryunosuke Hakuta, Yukiko Takayama, Yousuke Nakai

    With the increasing use of imaging modalities such as ultrasonography, computed tomography, and magnetic resonance imaging, incidental findings of pancreatic abnormalities, including pancreatic cysts and fatty pancreas (FP), have become more common. FP, also referred to as pancreatic steatosis, intra-pancreatic fat deposition, or fatty pancreas disease, is characterized by the accumulation of fat in the pancreas. Although FP has been associated with metabolic syndromes such as obesity and diabetes, its clinical significance remains unclear. Recent evidence suggests that FP may play a role in pancreatic carcinogenesis. Metabolic disorders, including obesity, insulin resistance, and diabetes, have been implicated in the development of FP. Additionally, FP has been linked to an increased risk of pancreatic ductal adenocarcinoma (PDAC), possibly due to chronic inflammation, lipotoxicity, and an altered pancreatic microenvironment. While early detection of PDAC remains challenging, surveillance strategies for high-risk individuals, such as those with pancreatic cysts, new-onset diabetes, or a genetic predisposition, may be crucial. In this context, FP may be incorporated into this surveillance of high-risk individuals. Some pharmacological interventions, including glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors, have shown potential in reducing pancreatic fat accumulation, although further studies are needed to confirm their efficacy.